Paper38554170
Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement.
Lalhmangaihzuala S and 6 others. Mol Divers, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement. Papers, record 38554170. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38554170
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carbohydrates | Major topic |
| Drug Delivery Systems | Major topic |
| Animals | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CRG/2022/000821 | Science and Engineering Research Board | PubMed |
Source PubMed
References218
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20219462 | Leishmania donovani: oral therapy with glycosyl 1,4-dihydropyridine analogue showing apoptosis like phenotypes targeting pteridine reductase 1 in intracellular amastigotes. | Exp Parasitol | 2010 | https://conductscience.org/library/papers/20219462 | PubMed |
| 2 | 20732810 | Design, synthesis, and anticancer activities of novel perfluoroalkyltriazole-appended 2'-deoxyuridines. | Bioorg Med Chem Lett | 2010 | https://conductscience.org/library/papers/20732810 | PubMed |
| 3 | 24139969 | Synergistic effects of pemetrexed and amrubicin in non-small cell lung cancer cell lines: Potential for combination therapy. | Cancer Lett | 2014 | https://conductscience.org/library/papers/24139969 | PubMed |
| 4 | 24284335 | Chitosan coupling makes microbial biofilms susceptible to antibiotics. | Sci Rep | 2013 | https://conductscience.org/library/papers/24284335 | PubMed |
| 5 | 23054107 | Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. | Ann Surg Oncol | 2013 | https://conductscience.org/library/papers/23054107 | PubMed |
| 6 | 23318809 | Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23318809 | PubMed |
| 7 | 20426497 | New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin. | Drugs | 2010 | https://conductscience.org/library/papers/20426497 | PubMed |
| 8 | 12754408 | Gold compound auranofin inhibits IkappaB kinase (IKK) by modifying Cys-179 of IKKbeta subunit. | Exp Mol Med | 2003 | https://conductscience.org/library/papers/12754408 | PubMed |
| 9 | 29846948 | Chitosan-based multifunctional nanomedicines and theranostics for targeted therapy of cancer. | Med Res Rev | 2018 | https://conductscience.org/library/papers/29846948 | PubMed |
| 10 | 30942528 | Marine glycan-based antiviral agents in clinical or preclinical trials. | Rev Med Virol | 2019 | https://conductscience.org/library/papers/30942528 | PubMed |
| 11 | 32933672 | Biomolecule chitosan, curcumin and ZnO-based antibacterial nanomaterial, via a one-pot process. | Carbohydr Polym | 2020 | https://conductscience.org/library/papers/32933672 | PubMed |
| 12 | 20180612 | Cethromycin: a promising new ketolide antibiotic for respiratory infections. | Pharmacotherapy | 2010 | https://conductscience.org/library/papers/20180612 | PubMed |
| 13 | 29503973 | Novel FR-900493 Analogues That Inhibit the Outgrowth of Clostridium difficile Spores. | ACS Omega | 2018 | https://conductscience.org/library/papers/29503973 | PubMed |
| 14 | 8878606 | Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8878606 | PubMed |
| 15 | 32020555 | Sodium Oligomannate: First Approval. | Drugs | 2020 | https://conductscience.org/library/papers/32020555 | PubMed |
| 16 | 9184373 | In-vitro activity of ketolides against mycoplasmas. | J Antimicrob Chemother | 1997 | https://conductscience.org/library/papers/9184373 | PubMed |
| 17 | 21107016 | Laninamivir and its prodrug, CS-8958: long-acting neuraminidase inhibitors for the treatment of influenza. | Antivir Chem Chemother | 2010 | https://conductscience.org/library/papers/21107016 | PubMed |
| 18 | 24897083 | Single-dose oritavancin in the treatment of acute bacterial skin infections. | N Engl J Med | 2014 | https://conductscience.org/library/papers/24897083 | PubMed |
| 19 | 26693943 | Activation of tumor suppressor p53 gene expression by magnetic thymine-imprinted chitosan nanoparticles. | Chem Commun (Camb) | 2016 | https://conductscience.org/library/papers/26693943 | PubMed |
| 20 | 31554958 | Recent advances in the biosynthesis of nucleoside antibiotics. | J Antibiot (Tokyo) | 2019 | https://conductscience.org/library/papers/31554958 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41155585 | Effects of Two Boron-Containing Compounds Structurally Related to Topiramate on Three Models of Drug-Induced Seizures in Mice. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41155585 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38554170
GET https://conductscience.org/api/papers/v1/38554170/references?page=2